Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
University of Washington
Study ID
NCT00030563
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

  • irinotecan hydrochloride — DRUG
  • adjuvant therapy — PROCEDURE
  • conventional surgery — PROCEDURE
  • radiofrequency ablation — PROCEDURE

Study Details

RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving a chemotherapy drug after surgery and radiofrequency ablation may kill any remaining tumor cells. PURPOSE: Phase II trial to determine the effectiveness of surgery with or without radiofrequency ablation followed by irinotecan in treating patients who have colorectal cancer that is metastatic to the liver.

Key Dates

Start date
May 31, 2001
Status verified
Apr 2017
Primary completion
Oct 31, 2004
Completion
Oct 31, 2005

Study Design

Primary purpose
TREATMENT

Locations (2)

FacilityCityStateZIPSite coordinators
Ireland Cancer CenterClevelandOhio44106-5065-
University of Washington School of MedicineSeattleWashington98195-

Find similar trials in Cleveland, OH

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
Ireland Cancer Center· Cleveland, OHUniversity of Washington School of Medicine· Seattle, WA

Related Studies